Global Custom Recombinant Protein Production Services Market to Reach $10.21 Billion by 2030 at 12.1% CAGR

Global Custom Recombinant Protein Production Services Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Custom Recombinant Protein Production Services Market Projected To Become By 2030 Based On Its 2026 Valuation?

The custom recombinant protein production services market has observed swift expansion over recent years. It is anticipated to increase from $5.79 billion in 2025 to $6.47 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.8%. The historical growth of this market is attributable to several factors, including the broadened scope of academic and clinical research, an elevated utilization of recombinant proteins in drug discovery, the expansion within biopharmaceutical R&D pipelines, the introduction of advanced expression technologies, and a growing demand for specialized research offerings.

The custom recombinant protein production services market is anticipated to experience significant expansion in the coming years. It is projected to reach a value of $10.21 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period is largely driven by the accelerating development of biologics and biosimilars, increasing investments in precision medicine, the expansion of contract research outsourcing, a rising demand for scalable protein production, and the greater adoption of advanced purification technologies. Foremost trends for this period include a heightened demand for custom protein expression services, the increased utilization of mammalian expression systems, a growing emphasis on high-purity protein production, the expansion of rapid turnaround research services, and an enhanced focus on quality control and validation.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33077&type=smp

What Major Drivers Are Influencing Demand In The Custom Recombinant Protein Production Services Market?

An increasing emphasis on targeted and personalized therapies is anticipated to stimulate the expansion of the custom recombinant protein production services market in the future. These medical treatments are designed to address individual patient characteristics, such as genetic profile or specific disease markers, with the goal of improving treatment effectiveness and reducing side effects. The surge in targeted and personalized therapies is attributed to advancements in precision medicine, which facilitates the tailoring of treatments to individual patient biology, thereby enhancing clinical outcomes and therapeutic efficiency. The custom recombinant protein production services support targeted and personalized therapies by providing precisely engineered proteins necessary for patient-specific drug development, biomarker targeting, and advanced biologic treatments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Consequently, the heightened attention on targeted and personalized therapies is driving the growth of the custom recombinant protein production services market.

What Segment Groups Are Identified Within The Custom Recombinant Protein Production Services Market?

The custom recombinant protein production services market covered in this report is segmented –

1) By Product: Antibodies; Enzymes; Cytokines; Growth Factors; Recombinant Hormones

2) By Expression System: Mammalian; Bacteria; Insect; Yeast; Other Expression Systems

3) By Application: Drug Discovery; Biopharmaceutical Production; Diagnostics Development; Academic Research; Industrial Enzymes

4) By End User: Research Institutes; Biotechnology And Pharmaceutical Companies; Contract Research Organizations (CROs); Other End-Users

Subsegments:

1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Chimeric Antibodies; Humanized Antibodies; Single Chain Antibodies

2) By Enzymes: Proteases; Lipases; Amylases; Cellulases; Polymerases

3) By Cytokines: Interleukins; Interferons; Tumor Necrosis Factors; Colony Stimulating Factors; Chemokines

4) By Growth Factors: Epidermal Growth Factors; Fibroblast Growth Factors; Vascular Endothelial Growth Factors; Transforming Growth Factors; Platelet Derived Growth Factors

5) By Recombinant Hormones: Insulin; Erythropoietin; Growth Hormone; Thyroid Stimulating Hormone; Follicle Stimulating Hormone

What Trends Are Advancing Progress In The Custom Recombinant Protein Production Services Market?

Major companies operating in the custom recombinant protein production services market are prioritizing the introduction of innovative microbial expression platforms, including their proprietary E. coli expression systems. This focus aims to boost protein production, enhance scalability, and reduce costs, thereby accelerating the delivery of next-generation biologics. A proprietary E. coli expression system is defined as a specialized, engineered E. coli bacterial strain utilized for producing recombinant proteins and plasmid DNA with high yield, stability, and efficiency, often customized for specific biotechnological or pharmaceutical applications. For instance, in March 2025, WuXi Biologics (Cayman) Inc., a China-based contract research, development, and manufacturing organization (CRDMO), launched its new EffiX Microbial Expression Platform. This platform boasts impressive titers exceeding 15 g/L for non-mAb recombinant proteins and more than 1 g/L for plasmid DNA. EffiX is positioned as a comprehensive solution for the development and manufacturing of microbial-derived biologics, improving scalability, quality, and productivity across the biopharmaceutical industry.

Which Global Companies Are Actively Competing In The Custom Recombinant Protein Production Services Market?

Major companies operating in the custom recombinant protein production services market are Thermo Fisher Scientific Inc., Merck KGaA, Applied Biological Materials Inc., R&D Systems Inc., GenScript Biotech Corporation, Sino Biological Inc, Biointron Biological Inc., OriGene Technologies Inc., Crown Bioscience Inc., Premas Biotech, Eurofins Discovery, ATUM, BPS Bioscience Inc., Novoprotein Scientific Inc., Kempbio Inc., Proteos Inc., Trenzyme GmbH, LakePharma Inc., Icosagen AS, and ProteoGenix SAS.

Read the full custom recombinant protein production services market report here:

https://www.thebusinessresearchcompany.com/report/custom-recombinant-protein-production-services-market-report

Which Region Is Expected To Experience The Fastest Growth In The Custom Recombinant Protein Production Services Market?

North America was the largest region in the custom recombinant protein production services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the custom recombinant protein production services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Custom Recombinant Protein Production Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33077&type=smp

Browse Through More Reports Similar to the Global Custom Recombinant Protein Production Services Market 2026, By The Business Research Company

Recombinant Proteins Market Report 2026

https://www.thebusinessresearchcompany.com/report/recombinant-proteins-global-market-report

Protein Engineering Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-engineering-global-market-report

Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model